Titelia

Holdings of NOVO HOLDINGS A/S

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
19 in 3 countries
Top ten
79.3 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Edgewise Therapeutics Inc 5,350,000168.5M $
2ASML Holding NV 94,946125.4M $
3MIRUM PHARMACEUTICALS INC 1,325,000122.4M $
4MAPLIGHT THERAPEUTICS INC 3,686,62274.9M $
5Salesforce Inc 393,18773.4M $
6Crinetics Pharmaceuticals Inc 1,550,00056.3M $
7Enliven Therapeutics Inc 1,280,00050.2M $
8VAXCYTE INC 860,00050M $
9ArriVent Biopharma Inc 1,942,14244.8M $
10VIRIDIAN THERAPEUTICS INC 2,000,00039.1M $
11Celldex Therapeutics Inc 1,200,00038.1M $
12Apogee Therapeutics Inc 450,00037.9M $
13BioMarin Pharmaceutical Inc 660,00037.3M $
144D Molecular Therapeutics Inc 3,650,73734M $
15Alibaba Group Holding Ltd 257,32732.3M $
16BridgeBio Oncology Therapeutics Inc 2,185,92319.6M $
17VALNEVA SE 1,057,4216.6M $
18LANZATECH GLOBAL INC 158,1482.5M $
19Marqeta Inc 441,5581.8M $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Technology 19.6 %
  • Consumer discretionary 3.2 %
  • Unattributed 77.2 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 87.0 %
  • Netherlands 12.4 %
  • France 0.7 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States17883M $86.99 %
2Netherlands1125.4M $12.35 %
3France16.6M $0.65 %
Cite this page

Titelia. "Holdings of NOVO HOLDINGS A/S". https://titelia.com/en/funds/US13F1388325